The Two Sigma Advisers LP Increases Position in Envision Healthcare Corp. (EVHC)

The Two Sigma Advisers LP Increases Position in Envision Healthcare Corp. (EVHC)

Two Sigma Advisers LP boosted its position in shares of Envision Healthcare Corp. (NYSE:EVHC) by 45.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 990,300 shares of the company’s stock after buying an additional 308,700 shares during the period. Two Sigma Advisers LP owned approximately 0.53% of Envision Healthcare Corp. worth $22,054,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Columbus Circle Investors bought a new stake in Envision Healthcare Corp. during the second quarter valued at about $20,343,000. Dimensional Fund Advisors LP raised its stake in Envision Healthcare Corp. by 44.1% in the second quarter. Dimensional Fund Advisors LP now owns 1,085,061 shares of the company’s stock valued at $27,529,000 after buying an additional 332,234 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Envision Healthcare Corp. by 7.1% in the third quarter. Ameriprise Financial Inc. now owns 1,430,590 shares of the company’s stock valued at $31,859,000 after buying an additional 95,353 shares during the last quarter. Kellner Capital LLC raised its stake in Envision Healthcare Corp. by 68.8% in the third quarter. Kellner Capital LLC now owns 283,000 shares of the company’s stock valued at $6,302,000 after buying an additional 115,300 shares during the last quarter. Finally, LS Investment Advisors LLC raised its stake in Envision Healthcare Corp. by 23.8% in the second quarter. LS Investment Advisors LLC now owns 5,066 shares of the company’s stock valued at $129,000 after buying an additional 974 shares during the last quarter. 34.68% of the stock is owned by institutional investors.

Envision Healthcare Corp. (NYSE:EVHC) opened at 68.92 on Thursday. The stock has a market capitalization of $3.71 billion, a P/E ratio of 21.27 and a beta of 0.71. The stock has a 50 day moving average price of $64.35 and a 200-day moving average price of $32.49. Envision Healthcare Corp. has a one year low of $18.31 and a one year high of $74.75.

Envision Healthcare Corp. (NYSE:EVHC) last released its quarterly earnings data on Tuesday, November 1st. The company reported $0.36 EPS for the quarter, meeting analysts’ consensus estimates of $0.36. Envision Healthcare Corp. had a return on equity of 8.05% and a net margin of 6.06%. The firm had revenue of $1.64 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the firm posted $0.30 earnings per share. The firm’s quarterly revenue was up 19.8% on a year-over-year basis. Analysts anticipate that Envision Healthcare Corp. will post $1.40 earnings per share for the current year.

Several equities research analysts have recently weighed in on EVHC shares. Oppenheimer Holdings Inc. upgraded Envision Healthcare Corp. from a “market perform” rating to an “outperform” rating and set a $87.00 price target on the stock in a report on Wednesday, December 7th. They noted that the move was a valuation call. Royal Bank Of Canada increased their price target on Envision Healthcare Corp. from $30.00 to $87.00 and gave the stock an “outperform” rating in a report on Thursday, January 5th. RBC Capital Markets increased their price target on Envision Healthcare Corp. from $30.00 to $87.00 and gave the stock an “outperform” rating in a report on Thursday, January 5th. Goldman Sachs Group Inc. started coverage on Envision Healthcare Corp. in a report on Friday, December 9th. They issued a “buy” rating on the stock. Finally, Citigroup Inc. upgraded Envision Healthcare Corp. from a “neutral” rating to a “buy” rating and reduced their price target for the stock from $27.00 to $26.00 in a report on Monday, September 26th. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. Envision Healthcare Corp. currently has an average rating of “Buy” and an average target price of $48.58.

Envision Healthcare Corp. Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corp. (NYSE:EVHC).

Related posts

Leave a Comment